Relieva
Relieva is redefining therapeutic innovation through the world’s first proprietary cannabis and hemp pre-roll blend engineered for targeted pain relief. Leveraging advanced cannabinoid and terpene research, Relieva integrates scientific precision, sustainable production, and blockchain-enabled IP tokenization to establish a new benchmark in functional medicine innovation and therapeutic transparency.
Community Sentiment
How do you feel about Relieva?
Project
Market Overview
Additional Documentation
Summary
The first tokenization of IP in the cannabis wellness and targeted medicine sector.
Problem
The first proprietary cannabis and hemp derived pre-roll blend designed for pain relief.
Impact
$25m in existing IP, assets and infrastructure to leverage off for the development of the new IP.
Tokenomics
10,000,000
Total SupplyIgnition Sale | 10% |
Wide Liquidity | 22.5% |
Concentrated Liquidity | 15% |
Team | 10% |
Treasury | 35% |
Bio Protocol Call Option | 2.5% |
veBIO Airdrop | 5% |
Stay up to date
Get the latest community updates and find out about upcoming Relieva developments